BTG International Ltd. (2011) Treatment of neurodegenerative conditions. JP2011144195.

Full text not available from this repository.

Abstract

To provide a method for treating a patient in need of therapy for a neurodegenerative disease.

SOLUTION: The method includes administering a therapeutically effective dose of a triglyceride oil containing both [gamma]-linolenic acid and linoleic acid residues as triglyceride ester, wherein the ratio of [gamma]-linolenic acid to linoleic acid residues at the sn-2 position of the triglyceride is at least 0.8; the amount of [gamma] -linolenic acid residues at the sn-2 position is at least 18%, wherein the oil is administered at a dose sufficient to maintain or elevate TGF-[beta]1 levels in the patient at a therapeutic level. Preferred oils are Borage or Mucor oils having at least 35% of the sn-2 position fatty acid residues as [gamma]-linolenic acid.

Item Type:	Patent
Uncontrolled Keywords:	multiple sclerosis, neurodegeneration, central nervous system
Subjects:	R Medicine > R Medicine (General)
Faculty / School / Research Centre / Research Group:	Faculty of Education, Health & Human Sciences > School of Human Sciences (HUM)
Last Modified:	09 Oct 2021 04:46
URI:	http://gala.gre.ac.uk/id/eprint/7157

Actions (login required)

View Item